Zocchi Michele L, Facchin Federico, Pagani Andrea, Bonino Claudia, Sbarbati Andrea, Conti Giamaica, Vindigni Vincenzo, Bassetto Franco
Plastic and Reconstructive Surgery Unit, University of Padua, Padua, Italy.
Remix Institute for Regenerative Surgery, Turin, Italy.
Eur J Plast Surg. 2022;45(1):1-25. doi: 10.1007/s00238-021-01874-6. Epub 2021 Oct 29.
Regenerative medicine and surgery is a rapidly expanding branch of translational research in tissue engineering, cellular and molecular biology. To date, the methods to improve cell intake, survival, and isolation need to comply with a complex and still unclear regulatory frame, becoming everyday more restrictive and often limiting the effectiveness and outcome of the therapeutic choices. Thus, the authors developed a novel 360° regenerative strategy based on the synergic action of several new components called the bioactive composite therapies (BACTs) to improve grafted cells intake, and survival in total compliance with the legal and ethical limits of the current regulatory frame. The rationale at the origin of this new technology is based on the evidence that cells need supportive substrate to survive in vitro and this observation, applying the concept of translational medicine, is true also in vivo. Bioactive composite mixtures (BACMs) are tailor-made bioactive mixtures containing several bioactive components that support cells' survival and induce a regenerative response in vivo by stimulating the recipient site to act as an in situ real bioreactor. Many different tissues have been used in the past for the isolation of cells, molecules, and growth factors, but the adipose tissue and its stromal vascular fraction (SVF) remains the most valuable, abundant, safe, and reliable source of regenerative components and particularly of adipose-derived stems cells (ADSCs). The role of plastic surgeons as the historical experts in all the most advanced techniques for harvesting, manipulating, and grafting adipose tissue is fundamental in this constant process of expansion of regenerative procedures. In this article, we analyze the main causes of cell death and the strategies for preventing it, and we present all the technical steps for preparing the main components of BACMs and the different mixing modalities to obtain the most efficient regenerative action on different clinical and pathological conditions. The second section of this work is dedicated to the logical and sequential evolution from simple bioactive composite grafts (BACGs) that distinguished our initial approach to regenerative medicine, to BACTs where many other fundamental technical steps are analyzed and integrated for supporting and enhancing the most efficient regenerative activity. Level of Evidence: Not gradable.
再生医学与外科是组织工程、细胞与分子生物学领域中快速发展的转化研究分支。迄今为止,改善细胞摄取、存活及分离的方法需要遵循复杂且仍不明确的监管框架,该框架日益严格,常常限制了治疗选择的有效性和结果。因此,作者基于几种新成分的协同作用开发了一种新型的360°再生策略,即生物活性复合疗法(BACTs),以提高移植细胞的摄取和存活率,同时完全符合当前监管框架的法律和伦理限制。这项新技术的基本原理基于这样的证据:细胞在体外需要支持性基质才能存活,而应用转化医学的概念,这一观察结果在体内同样成立。生物活性复合混合物(BACMs)是定制的生物活性混合物,包含多种生物活性成分,这些成分可支持细胞存活,并通过刺激受体部位充当原位真正的生物反应器来诱导体内再生反应。过去,许多不同的组织都被用于分离细胞、分子和生长因子,但脂肪组织及其基质血管成分(SVF)仍然是最有价值、最丰富、最安全且最可靠的再生成分来源,尤其是脂肪来源干细胞(ADSCs)的来源。整形外科医生作为所有最先进的脂肪组织采集、处理和移植技术的历史专家,在这一不断扩展的再生程序过程中起着至关重要的作用。在本文中,我们分析了细胞死亡的主要原因及预防策略,并介绍了制备BACMs主要成分的所有技术步骤以及不同的混合方式,以在不同临床和病理条件下获得最有效的再生作用。本文的第二部分致力于从区分我们最初再生医学方法的简单生物活性复合移植物(BACGs)到BACTs的逻辑和顺序演变,在BACTs中分析和整合了许多其他基本技术步骤,以支持和增强最有效的再生活性。证据水平:不可分级。